drugset / Trial / NCT03037944

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri

NCT03037944

Phase 0 Unknown 32 enrolled Ain Shams Maternity Hospital
RandomizedParallel-groupOpen-labelSupportive care

Summary

This study aims to compare the efficacy of LNG - IUD (Levonorgestrel releasing intrauterine device) Versus Low dose COCs (combined oral contraceptive pills) on management of heavy menstrual bleeding and Dysmenorrhea caused by Adenomyosis.

Timeline

Start
2016-03-01
Primary completion
2017-12-01
Completion
2018-12-01

Publications

  • Results Benagiano, G.; Brosens, I.; Habiba, M.

Drugs

EvaluationDrugModalityDoseRoute
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 0.03 mg Oral

Indications